Skip to content

Author

Y. Kataoka

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Circulating angiopoietin-like protein 3 levels and subsequent cardiovascular outcomes in patients with coronary artery disease

Angiopoietin-like protein 3 (ANGPTL3) is a secretory glycoprotein mainly expressed in the liver, which regulates metabolism of triglyceride-rich lipoproteins. Pathophysiologically, ANGPTL3 inhibits lipoprotein lipase activity and endothelial lipase activity, which diminishes the clearance of triglyceride-rich lip...

S. Fujita, Y. Kataoka, N. Kuyama et al. · 0 citations
Open access Oct 2026

Clinical impact of more than 50% reduction in low-density lipoprotein cholesterol at 6 weeks after percutaneous coronary intervention for acute coronary syndrome

Early intensive lipid-lowering therapy is recommended after acute coronary syndrome (ACS), and current guidelines recommend assessing attainment of lipid-lowering targets within 4–6 weeks; however, the prognostic significance of achieving a more than 50% reduction in low-density lipoprotein cholesterol (LDL-C) sh...

K. Murai, K. Mitsui, T. Iwai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.